metastatic prostate cancer

Touting a wad of cash in the wake of a clinical implosion, a small biotech reviews some limited options
Endpoints
Tue, 03/29/22 - 10:45 am
Tyme Technologies
clinical trials
SM-88
metastatic prostate cancer
NantKwest and ImmunityBio to initiate a phase 2 study of immunotherapy for metastatic pancreatic cancer
Pharmaceutical Business Review
Fri, 05/15/20 - 10:29 am
NantKwest
clinical trials
t-aNK
metastatic prostate cancer
J&J scores another PhIII win for Erleada as it continues to build a blockbuster franchise
Endpoints
Wed, 01/30/19 - 11:47 am
JNJ
Erleada
prostate cancer
metastatic prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
CP Wire
Thu, 12/20/18 - 10:27 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Astellas and Pfizer's Xtandi Meets Primary Endpoint in Ph III Trial of Metastatic Prostate Cancer
Thu, 12/20/18 - 10:19 am
Astellas
Pfizer
Xtandi
prostate cancer
metastatic prostate cancer
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Fierce Biotech
Tue, 11/27/18 - 11:35 pm
Halozyme
clinical trials
PEGPH20
metastatic prostate cancer
Battered ArQule shares bump up on badly needed positive data for tivantinib
Fierce Biotech
Mon, 11/10/14 - 11:13 am
Arqule
tivantinib
metastatic prostate cancer
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Sun, 06/1/14 - 11:40 am
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Jevtana (cabazitaxel) Injection Now Available in the U.S.
Mon, 07/19/10 - 01:36 pm
Jevtana
Sanofi
metastatic prostate cancer